The in vivo kinetic analysis of dopamine D 2 receptors was obtained in baboon brain using positron emission tomography (PET) and C6Brjbromolisuride W6BrjBLlS) as radioligand. An injection of a trace amount of C6BrjBLlS was followed 3 h later by an injec tion of a mixture of C6BrjBLlS and BLIS in the same syringe (coinjection experiment). A third injection per formed at 6 h was either an excess of unlabeled ligand (displacement experiment) or a second coinjection. This protocol allowed us to evaluate in the striatum of each animal and after a single experiment the quantity of avail able receptors (B:naJ and the kinetic parameters includ ing the association and dissociation rate constants (k + I V R and k _ l' respectively, where V R is the volume of reac tion). The cerebellum data were fitted using a model with out specific binding. All the parameters were estimated
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The dopaminergic system was the first neuro transmission system in which it was possible to im age receptors, stored neurotransmitters, and neuro transmitter reuptake mechanisms. For a long time, most researchers endorsed the hypothesis that there were at least two major dopamine receptor types: DJ receptors linked to the stimulation of ade nylate cyclase and D2 receptors linked to the inhi bition of this enzyme (Kebabian and CaIne, 1979) .
Very recently, a D3 dopamine receptor with no ef fect on adenylate cyclase was characterized (Sokoloff et al., 1990) . Research on D2 dopamine receptors has considerably developed because of using nonlinear mathematical models of the ligand receptor interactions including or not including nonspe cific binding. The plasma time-concentration curve was used as an input function after correction for the metab olites. An estimate of standard errors was obtained for each PET study and for each identified parameter using the covariance matrix. The average values of B:n ax and Kd V R were 73 ± II pmollml tissue and 1.9 ± 0.9 pmollml, respectively. The nonspecific binding was identifiable in the experiment where the last injection corresponded to a second coinjection. We found that �6% of the striatal binding was nonspecific after a tracer injection of C6Brj BLIS. The nonspecific binding appeared to be reversible in the striatum but irreversible in the cerebellum. Key Words: D 2 Dopamine receptors-C6Br]Bromolisuride Positron emission tomography-Compartmental model. the availability of several selective antagonist neu roleptics. It is generally assumed that the antipsy chotic (as well as the extrapyramidal) effects of neuroleptics are mediated by a blockade of D2 re ceptors because the correlation between the anti psychotic potency of these drugs and their in vitro affinity is good. The possibility of visualizing dopa mine receptor-enriched structures in a living animal was first demonstrated in 1982, using spiperone la beled with the "y emitter 77Br (Friedman et al., 1982) . This experiment revealed the interest of bu tyrophenones and later of central dopamine D2 re ceptors that were visualized in vivo in human or primate basal ganglia using spiperone derivatives labelled with the positron emitters lIC, 1 8 F, and 76Br (Wagner et al., 1983; Arnett et al., 1984 Arnett et al., , 1986 Maziere et al., 1985; Satyamurthy et al., 1986; Shiue et al., 1987) . However, spiperone and its de rivatives also have in vivo high affinity for central serotonin receptors (Frost et al., 1987; Coenen et al. , 1988) . Research on the development of more spe cific Dz ligands has shown the potential of other series of dopamine antagonists, such as benzamide and ergolene analogues. Among the benzamides, raclopride was labeled with IIC and successfully used for the selective analysis by positron emission tomography (PET) of central Dz receptors in pri mates and humans (Farde et al., 1985) . Among the ergolene derivatives, 2-bromolisuride (BLIS) has specific antidopaminergic properties. After labeling with 76Br, BLIS appears to be a suitable selective ligand for the in vivo characterization of Dz recep tors in humans . Compared to spiperone derivatives, this ligand has a more spe cific (no binding on 5-HTz receptors), faster, and more reversible specific binding.
Ne uroreceptor imaging has progressively evolved from simply quantifying ligand brain up take to measuring the actual parameters of the ligand-receptor binding. Different biomathematical models (dynamic or equilibrium models) have been proposed. These new possibilities open the way to the investigation of dopamine Dz receptors in phys iology, clinical pharmacology, and neurological and psychiatric disorders.
Several models have recently been proposed as a framework for analyzing kinetic data of ligand receptor interactions studied with PET (see Mintun et al., 1984; Syrota et al., 1984; Vera et al., 1985; Perlmutter et al., 1986; Wong et al., 1986) . In these models, the reactions are usually considered as a two-step process: The free ligand is first trans ported from blood to tissue where binding sites are located and the ligand-receptor complex is then formed. However, the model structure may differ depending on the organ, the molecule, or the exper imental protocol used. For example, the binding of ligands can be reversible or not, a nonspecifically bound ligand compartment may be introduced [see detailed and critical reviews of the quantitative models in Huang et al. (1986) , Perlmutter et al. (1986) , and Logan et al. (1987) , for example]. Ac cording to the model structure, the number of model parameters used in this field are four to eight, which usually must be identified from a single curve.
However, it is well known that when the number of parameters is too large compared with the exper imental data, two difficulties may appear. First, the uncertainties of parameters may be so large that the identified values are meaningless. Second, the iden tification problem may have several distinct solu tions; i.e., several very distinct sets of parameter values lead to similar theoretical curves (Delforge et al., 1990) . In both cases, the identification proce-dure may not lead to a valid solution. The necessary balance between the respective complexities of a model structure and experimental data corresponds to a general mathematical problem known as the identifiability problem (Delforge et al., 1990) .
When previous experimental results have shown, for example, that the specific binding is reversible and the nonspecific binding is not negligible, the number of model parameters is equal to seven or eight and cannot be reduced. Usually, some hy potheses are introduced to simplify the model, such as some equilibrium hypotheses, or to identify only a part of the model [for example, for a Dz receptor binding model, by assuming that the concentration in the cerebellum is similar to the concentration of the free ligand in the striatal tissue, we neglect the identification of the parameters associated with the ligand transport between blood and tissue (Farde et al., 1989) ]. These sorts of hypotheses are very use ful because they often provide a way of estimating the concentration of receptors. However, the vali dation of these hypotheses is not always easy.
In this study performed with C6Br]BLIS in ba boons, we chose to make no particular hypothesis and to identify all the model parameters from a sin gle PET experiment. Obviously, this imposes the use of an experimental protocol that is complex enough to obtain the necessary experimental data, allowing a unique and accurate identification of the model parameters.
METHODS

Animal preparation
Male Papio papio baboons, weighing 11-14 kg, were anesthetized and immobilized according to a previously described procedure (Maziere et aI., 198\) . All animals had undergone an endotracheal intubation and were ven tilated with room air by a respirator. A catheter to inject the ligand was placed in a brachial vein and a second catheter was inserted in the femoral artery to withdraw arterial blood.
Preparation of [
76 Br ]BLIS 76Br was produced by irradiation of arsenic with a beam of 30 Me V 3He ions. The target was dissolved in hot sulfuric acid and the radioactive bromine was distilled after oxidation with chromic acid and trapped as bromide in diluted ammonia that was later taken to dryness. Non carrier-added C6Br]BLIS was prepared by an electro philic substitution reaction (Loc'h and . 76Br 2 generated in situ from C6Br]NH4 by peracetic acid was allowed to react for 30 min with an excess of lisuride. The radiobromo compound was separated from the cold precursor and other side products by HPLC on a silica gel column (Lichrosorb Si60, 250 x 10 mm; Merck) and chlo roform/methanollwater/ethylamine (990:9:0.5:0.5 vollvoll vollvol) as mobile phase. The simultaneous recordings of the UV (254 nm) and the radioactivity signals allowed the recovery of C6Br]BLIS. The injectable solutions were prepared by dissolving the radioligand and cold BLIS in diluted acetic acid, filtration through a 0.22-!Lm polytet rafluoroethylene membrane, and neutralization to pH 4 with diluted NaOH. The specific activity of C6Br]BLIS so prepared ranged from 0.2 to 3 Ci/!Lmol (7-110 GBq/ !Lmol). Chemical and radiochemical purities assessed by HPLC and thin layer chromatography (TLC) analysis were >99%.
Experimental protocol
Five PET experiments were performed on baboons. The protocol consists of three injections of radiolabe1ed [76Br]BLIS and/or BLIS.
At the beginning of the experiment (time 0), 0.5-4 nmol of C6Br]BLIS (0.6-1.4 mCi) was intravenously injected for -45 s. Three hours later (time 3 h), a mixture of la beled and unlabeled BLIS in the same syringe was ad ministered (coinjection experiment). At this time, the in jected C6Br]BLIS amount ranged from I to 7 nmol, that of unlabeled ligand from 100 to 350 nmol.
The third injection, performed 3 h later (time 6 h), was dependent on the experiment. For the first two experi ments (procedure A), an additional intravenous injection of an excess of unlabeled ligand was given (646 and 1,185 nM, respectively). This represented a displacement ex periment. For the last three experiments (procedure B), the third injection consisted of a second coinjection ex periment as 6-10 nmol of C6Br]BLIS and 900-2,300 nmol of BLIS were simultaneously injected.
The whole duration of the experiment was 9 h. All C6Br]BLIS needed for an experiment was produced by the same synthesis so that the specific radioactivity mea sured at time 0 was identical in the two or three injec tions. The details of the doses administered are given in Table 1 .
PET measurements
PET studies were performed using the seven-slice time of-flight assisted positron camera (Soussaline et aI., 1985) (LET! TTVOl; CEA, France). Each slice was 13 mm thick and spatial transverse resolution was -12 mm. Transmission scans were performed with a rotating 68Ge_ 68Ga source to correct emission scans for the attenuation of 51l-keV photon rays through the tissues. Emission data were recorded in list mode starting with the first injection of C6Br]BLIS until the end of the experiment.
About 60 sequential images were reconstructed accord ing to the experimental protocol for each animal. The images showing two of the seven cross sections that in tersected the striatum and the cerebellum were selected for analysis. For the cerebellum, an 80% isocontour was selected on an early 10-min image and two circular re gions of interest (ROls) (3.3 cm2) were placed on each cerebellar hemisphere. For the striatum, two circular ROls (0.9 cm 2 ) were placed according to the 80% isocon tour ROI that was selected on the 170-to 180-min image.
Radioactivity was measured in each cerebral structure after correction for 76Br decay and expressed as pico moles per milliliter after normalizing by the specific ra dioactivity measured at time O.
Correction of partial volume effects for a small structure like the striatum was performed using the data obtained with a baboon brain phantom composed of two compart ments. The first one, a sphere filled with 76Br (tl12 = 16.2 h), represents the striatum. The second compartment, a cylinder filled with 68Ga (tl/2 = 68 min), represents the surrounding structure of the brain. At the beginning of the PET measurements, the radioactivities in both compart ments (expressed in counting rate) were identical. Five hours later, owing to different physical radioactive decay, the ratio became 17. After reconstruction of the PET im ages (60 sequential images, 5 min each), ROIs were po sitioned in the two compartments. Radioactive concen trations of the ROls were calculated and compared with the theoretical values. The recovery yield of the radioac tivity concentration in the striatum-like sphere was ana lyzed and compared with the experimental radioactivity concentration ratio in the two components. This function was used to correct the data obtained in the baboon stud ies. This correction method has been validated in in vivo experimental conditions in baboons injected with 2 mCi of C6Br]BLIS (specific activity 0.002-1 mCi/nmo!). Three hours later, just after PET measurements, the animal was killed and the brain dissected. All the cerebral structures were weighed and the tissue radioactivities measured us ing a 'Y counter. In four experiments, the 76Br striatal radioactivity concentration measured by PET represents only 20-40% of the accurate values. After correction, the estimated in vivo radioactive concentration values in the baboon striata represent 91 ± 12% of the ex vivo values.
Plasma radioactivity concentration measurements
To identify the model parameters, knowledge of the plasma time-activity curve C�(t) is necessary because it is used as the input function in all subsequent modeling. About 70 arterial blood samples (-0.3 m!) were collected from the femoral artery. The time interval between each sample was varied to improve the accuracy of the param eter identification. Samples were taken every 10 s for 2 min after each injection of labeled BLIS. The sampling interval increased to 20 min when blood radioactivity reached a plateau. After rapid blood centrifugation, the plasma 76Br radioactivity was measured using a "y count ing system. Then, the time-activity curves were corrected for physical decay of 76Br activity. After metabolite cor rections, the plasma radioactivity concentrations were transformed in BLIS time-concentration curves using the specific radioactivity of C6Br]BLIS.
Metabolite measurements
The plasmatic proteins were eliminated by precipita tion with methanol. After centrifugation, the supernatant was evaporated to dryness and the residue, dissolved in a few microliters of methanol, was applied on a TLC sil ica gel plate using chloroform/methanollethylamine (90: 10:0.1). After migration, the unchanged radioligand was measured using a static radio chromatogram analyzer (Loc'h et aI., 1989; Maziere et aI., 1989) .
The ligand-receptor model
The compartmental model used in this study and shown in Fig. 1 is a nonequilibrium nonlinear model (Syrota et aI., 1984) . The flux of unmetabolized free ligand from 
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Concentration k compartment 1 to compartment 2 is given by PVRC�(t) (pmollmin/ml tissue). C�(t) is the plasma concentration of unmetabolized C6Br]BLIS, P (mllmin/ml) is a rate con stant, and V R (mllml) is defined as the fraction of the ROI delineated by PET in which the ligand can react with receptors. The quantity of radioactive free ligand present in I ml of the extravascular extracellular volume (com partment 2) is denoted by M;, which could be restricted merely to a boundary layer (Syrota et aI., 1985) . The free ligand could bind directly to a free receptor site or to a nonspecific site or could escape with a rate constant k.
The specific binding probability depends on the bimolec ular association rate constant k + I and on the local con centration of free receptor sites, which is equal to [B:n ax -M�(t)]. The parameter B :n ax represents the unknown quantity of receptor sites available for binding and M�(t) is the quantity of labeled ligand bound to receptors in 1 ml of tissue. The nonspecific binding probability of the free ligand is denoted by k + ns ' The rate constant for the dis sociation of the specifically bound ligand is denoted by k_l, that for the nonspecifically bound ligand by k _ ns • Thus, the model has four compartments: a compart ment in which ligand concentration is equal to plasma concentration (compartment 1); an extravascular, extra cellular space occupied by free ligand (compartment 2); a compartment corresponding to specifically bound ligand (compartment 3); and a compartment including the non specifically bound ligand (compartment 4). This model contains seven parameters, the two most important being the concentration of receptor sites avail able for binding B:nax and the ratio of k _ l to k + 1 defining the equilibrium dissociation constant Kd• The protocol described in the previous section includes injections of unlabeled ligand during displacement and coinjection experiments. Thus, the kinetics of the unla beled ligand affect the local concentration of free recep tors and must therefore be taken into account. Amounts of free unlabeled ligand are denoted by Mit), specifically bound unlabeled ligand by Mb(t) , and nonspecifically bound unlabeled ligand by Mns(t). They are expressed as picomoles per milliliter tissue.
Parameter identification and simulations of labeled and unlabeled ligand kinetics were performed using the fol lowing equation system (which corresponds to the model diagram of Fig. 1) :
where B:nax, pVR, k, k +IIVR, k _l, k +ns' and k _ns are the unknown parameters. Units are given in Table 2 .
In PET studies, experimental data [denoted by M{(tJl acquired between two times (denoted by ti_1 and t) are given by the following integral relation:
where C�(t) is the whole-blood time-concentration curve and F v represents the fractional volume corresponding to the fraction of blood present in the tissue volume. In this study, F v is assumed to be 0.04 (Perlmutter et aI., 1986; Farde et aI., 1989) . 1.9 ± 0.9 c The nonspecific binding was not identifiable from the protocol used during the first two experiments. Where applicable, the first number corresponds to the identified parameter value using the model without nonspecific binding; the second is the parameter value obtained by setting the value of k+ ns and k_ ns to 0.040 min -I and 0.014 min -I, respectively (the average of the values identified from the last three experiments).
d Nonfitted parameters. e Kd = k_l/k+ 1 •
RESULTS
Plasma time-activity curves and model input fu nctions
The plasma concentration measurements, shown in Fig. 2 by filled circles, correspond to those of experiment 3. After each of the three injections of C6Br]BLIS, plasma radioactive concentration in creased rapidly and reached a maximum within the 30 s following the end of the injection (10.9 ± 1.3 pmol/ml/nmollkg injected). Then, the curves fell to low values within 5 min after injection and remained almost constant until the next injection. The level of each plateau was proportional to the sum of the doses of C6Br]BLIS injected from the beginning of the experiment (1.04 ± 0.27 pmollmllnmol/kg in jected).
In all five experiments, the unchanged BLIS per centages in the plasma were measured five or six times between the first and the second injection.
The results corresponding to the five experiments are shown in Fig. 3 and are fitted to a biexponential curve: It has been previously shown that BLIS metabo lites are polar compounds that cannot cross the blood-brain barrier (Loc'h et aI., 1989; Maziere et aI., 1989) . So we used the unmetabolized C6Br] BLIS plasma concentration as the input function in corresponding to experiment 3 (exact doses are given in Ta ble 1). The three pea ks corresponding to the injections of labeled ligand (0, 3, and 6 h) are easily observable. For a few minutes after an injection and until the next injection, the plasma concentration curve, uncorrected for metabolites, appears as a plateau, whereas the unmetabolized [76Brlbro molisuride concentration curve, used as the input function in the model, decreases regularly to a much lower level. the curve C;(t) was the product of the blood 76Br concentration and P nm(t)/lOO. After the second in jection, we estimated the 76Br concentration corre sponding to the first injection of C6Br]BLIS by ex trapolating the plateau (we assumed that without the new injection the plasma time-activity curve would remain about constant). Therefore, by sub tracting, we estimated the plasma 76Br concentra tion corresponding to the second injection. Then the unmetabolized C6Br]BLIS concentration corre sponding to each injection was estimated using the biexponential function Pnm(t). The method was the same after the third injection by extrapolating the two plateaus. In Fig. 2 , the estimation of unmetab olized C6Br]BLIS plasma concentration corre sponding to experiment 3 is shown by the solid line. It was also necessary to know the time-blood concentration curve of the unlabeled BLIS denoted by Cp(t). This curve was estimated from C;(t) by assuming that the unlabeled ligand kinetics were similar to those of the labeled ligand. In preliminary experiments, we demonstrated that the percentage of unchanged BLIS in plasma was identical, what ever the injected dose (0.2-70 nmol/kg).
After the first coinjection at 3 h, the plasma con centration of unmetabolized unlabeled ligand was estimated by multiplying the unmetabolized plasma concentration of labeled ligand resulting from the second injection by the ratio of the corresponding doses (JzlJ!; see values in Table O . After the sec-ond coinjection (procedure B), Cp(t)t E [ 6 h , 9 hJ was obtained by adding the two curves corresponding to the two BLIS injections.
After a displacement experiment (third injection of procedure A), the unmetabolized unlabeled li gand was estimated by a similar method using the unmetabolized plasma concentration of labeled ligand following the first injection and the ratio 13/Jj (see values in Table O .
Striatum and cerebellum time-concentration curves
The experimental data obtained both in striatum and in cerebellum during experiment 1 (using pro cedure A) and during experiment 3 (using procedure B) are shown in Figs. 4 and 5, respectively. After the first injection of C6Br]BLIS with high specific activity, the radioligand concentration in the stria tum increased very slowly and the maximum (5.7 ± 0.9 pmollmllnmollkg injected, n = 5) was reached only � 100 min after the injection. In contrast, the cerebellum concentration reached a maximum (1.2 1 ± 0.27 pmol/mllnmollkg injected) within the first minutes after the injection.
After the coinjections, the larger the injected un labeled ligand doses, the faster were the initial in creases and the more rapidly the maximums were reached. See in Figs. 4 and 5 the initial injections (high specific activity), the second injection in Fig.   4 (12 = 97 nM), and the second and the third injec tions in Fig. 5 (12 = 297 nM and 13 = 1,�20 nM). In contrast, the shape of the curves corresponding to Table 1 ). BLlS, bromolisu ride.
the cerebellum appeared to be independent of the unlabeled ligand doses. An injection of a large amount of unlabeled ligand (third injection of procedure A; see Fig. 4 ) resulted in a slow decrease in the striatum concentration corresponding to a slow dissociation of the labeled bound ligand. This injection of BLIS did not modify the C6Br]BLIS concentration in the cerebellum (see Fig. 4 ).
Parameter identification
Fitting the complete mathematical model to ex perimental data provided values for kinetic rate constants and receptor densities as shown in Table  2 (striatum) and in Table 3 (cerebellum).
The striatum data obtained using procedure A (experiments 1 and 2) were fitted considering the model shown in Fig. 1 without nonspecific binding . The final quality of the fit obtained with this model, including only five parameters, was satisfactory as can be seen in the example of Fig. 4 (solid line) . Therefore, in this case, if nonspecific binding were included in the model, unidentifiable parameters would result. However, with the data obtained us ing procedure B (experiments 3, 4, and 5), the fits obtained with this five-parameter model were never satisfactory, particularly in the last 3 h of the ex perimental curve. Therefore, the striatum data cor responding to procedure B have been fitted by the model including seven parameters (see example in Fig. 5 ).
An estimate of standard error was obtained for A verage parameter values and standard devia tions were calculated for the five animals. The re ceptor density was 73 ± 11 pmollml striatal tissue and the product KdVR was 1.9 ± 0.9 nmollL. The relative standard deviations ranged from 10 to 30% for all parameters except for parameters Kd V R (55%) and L 1 (42%). These standard deviations have the same order of magnitude of the standard errors estimated for each experiment and each pa rameter by the method described in Appendix.
Because it has been demonstrated that the con centration of dopamine D2 receptors is negligible in cerebellar tissue (Kuhar et al., 1978; Martres et al., 1985) , the cerebellum data have been fitted using the model shown in Fig. 1 without specific binding and thus including only four parameters. However, in the four experiments, the identified values of the parameter k_ns are very small «0.000 1 min -1 ) and the corresponding estimated standard errors are much larger than the identified values. This means that this parameter k _ ns is equal to zero or is so small that it cannot be identified from the available experimental data. Consequently, the model used to fit the cerebellum data included an irreversible nonspecific binding, and thus only three parame ters. This explains the plateaus observed in the cer ebellum curves (Figs. 4 and 5) .
Computer simulations
Striatum concentration-time curves for the free, bound, and total ligand can be calculated using the model and the parameter values shown in Table 2 . Figure 6 shows the result of the simulation obtained with the parameters estimated from experiment 3. The concentration measured with PET is the sum of C6Br]BLIS concentration in compartments 2, 3, and 4 and a fraction of compartment 1 estimated to 4% and corresponding to the vascular fraction in the ROI. Computer simulations showed that most of the radioligand was specifically bound to receptors after the first high specific activity injection (89% at 100 min). After an initial peak, the percentage of free ligand was equal to 4% at 100 min and de creased slowly, whereas the percentage of nonspe cifically bound ligand remained at �6%.
After the first coinjection (time 3 h), the simula tion of the labeled and unlabeled ligand kinetics showed that the maximum concentration of specif ically bound ligand was reached �25 min after in jection (see Figs. 6 and 7, time 205 min) . At this time, �75% of the receptor sites were occupied by unlabeled ligand and � 2 . 6% , by labeled ligand. Be cause the probability of specific binding is propor tional to the concentration of free receptor sites (see The Ligand-Receptor Model), it was divided by �4.5 with respect to the probability corresponding to the first tracer injection. This explains why the percentage of specifically bound ligand was de creased after the second injection. For example, at 250 min, the percentage of specifically bound C6Br]BLIS was only 74%, whereas the percentages of C6Br]BLIS in the free ligand compartment and in the nonspecific ally bound ligand compartment were 8 and 15%, respectively. The dose of unlabeled BLIS injected at 6 h was very large and the simulation showed that, at the maximum occupancy (� 15 min after this last injec tion), �96.2% of the receptor sites were occupied by unlabeled ligand and �2.9% by labeled ligand, therefore a total percentage equal to 99. 1%. This explains the very small peak in the specifically bound radiolabeled ligand concentration and the relative increase of the concentrations in the other compartments. At the end of the experiment (time 9 h), the percentages of free ligand, specifically bound ligand, and nonspecifically bound ligand were 9, 57, and 29% of the total ligand, respec tively.
DISCUSSION
We have seen in Parameter Identification that it was impossible to point out a nonspecific binding from the striatum data obtained during the first two experiments using procedure A. To allow identifi cation of possible nonspecific binding, we modified the protocol so that the percentage of nonspecific binding became maximal. It is not surprising that simulations showed that the best method to in- Vol. 11, No.6, 1991 crease the nonspecific binding was to saturate all the receptor sites using an injection of a load of cold ligand together with the labeled ligand. In this case, the concentration of labeled free ligand and thus, according to the model structure, the probability of nonspecific binding were maximal. Therefore, the last injection was modified and consisted, in proce dure B, of an injection including both an excess of unlabeled ligand and a tracer dose of labeled ligand. As foreseen by the simulations, the percentage of nonspecific binding in the striatum was � 30% after the last injection (see Computer Simulations). In these conditions, the use of a model without non specific binding led to an unacceptable fitting result (see Parameter Identification). Therefore, and as shown in Table 2 , the striatum data obtained with procedure B allowed the identification of the asso ciation and dissociation rate constants of the non specific binding. Parameters k +ns and k _ns were found to be 0.040 ± 0.005 and 0.014 ± 0.006 min -I, respectively. Comparing k + ns with k 3 (the com bined parameter B'maxk + I IV R used in various mod els) shows that �6% of the binding was nonspecific after a tracer injection of C6Br]BLIS. It is also in teresting to note that the dissociation rate constants of the specific and nonspecific binding are very close (both parameters k _ ns and k _ 1 are equal to 0.0 14 min -I in Table 2 ).
We have fit the seven-parameter model to the striatum data obtained with the first two experi ments by setting the values of k + ns and k _ ns to the values identified from the last three experiments. The results obtained by this method (see Table 2) were not very different from the values obtained when the nonspecific binding was neglected. For example, the relative difference of B'max values es timated by the two methods was only 4%.
Comparing the mpdel parameters corresponding to the striatum and the cerebellum shows that the kinetics are slower in the cerebellum. The values of parameters p V R and k, corresponding to the transfer between the blood and the free ligand compartment, are smaller in the cerebellum than in the striatum (see Tables 2 and 3) , but the partition coefficients (the ratiospVRlk) are similar in the two tissues (1.84 and 1.54, respectively).
The quantity of receptor sites available for in vivo binding B'max estimated by this modeling approach was found to be 73 ± 11 pmoIlml. This value is close to the values previously obtained in baboon using the same ligand in vivo with an equilibrium ap proach [Maziere et al. (1990) (Wagner and Wong, 1990) . The Kd V R value determined by this model was 1.9 ± 0.9 nmol/L. This value has the same order of magnitude as that previously obtained using the same ligand in vivo with an equilibrium approach [Maziere et al. (990) : 0.6-0.7 nmol/L; Hantraye et al. (199 1) : 1.9 ± 0.3 nmoIlL]. By an in vitro method, the equilibrium dissociation constant Kd was found equal to 0.30 ± 0.04 nmol/L (Maziere et aI., 1990) . Prom these results, the volume of reaction VR can be estimated to be equal to 6.3 mllml. It is not sur prising that this value is > I because of the li pop hili city of the BLIS (log Poct/water = 3. 1). Such a volume of reaction can also be observed with [l 1 C]raclopride where the comparison of Kd in vivo (3.8 nmollL) and in vitro 0.1 nmollL) leads to a volume of reaction equal to 3.5 ml/ml (Farde et aI., 1986 (Farde et aI., , 1989 ).
CONCLUSION
The model approach allowed the quantification of the D2 receptors in vivo in primates. Because of the complexity of the model, the identification of all parameters imposed a multiinjection protocol. The identification of the seven parameters was possible only with at least three injections of labeled and/or unlabeled ligand.
However, such a sophisticated study should al low us first to validate a possible simplified model ing using a protocol that leads to a quantification of B:nax and second to justify the use of some indexes when the interest is to show only the relative vari ation of B:nax without absolute quantification.
We are presently studying the possibility of sim plifying the model and the experimental protocol to make this approach more suitable for human stud ies. For example, if we consider that the nonspe cific binding (6% after a tracer injection) can be ignored, the identification of the five-parameter model can be possible with two injections (Delforge et aI., 1990) . However, the main difficulty is the duration of the experiment, which is due to the length of time necessary for the BLIS concentration to reach a maximum after an injection. This time, which is much longer than that observed with usual molecules used in PET study, is not due to a small concentration of receptors but to a very low asso ciation rate constant.
In a clinical situation, the results of PET receptor studies are often expressed in terms of radioactive ratios (Baron et aI., 1986) . In the case of D2 recep tors, where the cerebellum is virtually devoid of specific binding sites, the striatum/cerebellum ra dioactive concentration ratio is used as an index of striatal specific binding. Using the model described in Fig. 1 and the parameters given in Table 2 , we have simulated the relation between the striatum/ cerebellum ratio and the receptor concentration. The results of this simulation (Fig. 8) show that the B:nax and the striatum/cerebellum ratio are posi tively correlated. Assuming that nonspecific bind ing, affinity, and access to the receptors are stable, the striatum/cerebellum ratio can then be consid ered a reliable index of striatal D2 receptor density.
APPENDIX: MATHEMATICAL METHODS
Parameter identification
To identify the model parameters, we define a cost function allowing measurement for a given pa rameter set, of the differences between the experi mental data and the corresponding values predicted by the model. Parameter identification is performed by choosing those parameter values that minimize the cost function (Beck and Arnold, 1977) . In this study, model parameters are identified by means of minimization of a usual weighted least-squares cost function defined by Simulation of the striatum/cerebellum radioactive concentration ratio as a function of the receptor concentra tion B;"ax' We used the model described in Fig. 1 and the model parameters given in Table 2 .
corrected measures {Yet) }, P = [PI' P2' ... , PrY represents the model parameters, and Yeti' P) are the values predicted by the model from parameter P and from the experimental protocol. The simulated curves Yeti' P) are calculated using a Runge-Kutta fourth-order method (Pizer, 1975) . The weights Wi were defined as Wi = (ti -ti-I)ly(t) (Mazoyer et al., 1986) . The cost function was minimized by us ing a Marquardt algorithm (Marquardt, 1963) . Pa rameter P corresponding to the minimum of D(P) is the best estimate and is denoted by �.
Error analysis
The evaluation of the parameter uncertainties is essential in any complete identification procedure. We have used the classic approach where the infor mation matrix and the measure of residual differ ences between experimental data and model pre dicted values allow us to generate an approximate parameter covariance matrix and to deduce an es timation of the standard error of each parameter.
Sensitivity functions are the derivatives of the theoretical function Yet, P) with respect to the pa rameters and can always be calculated using a nu merical procedure. Let Sk(t, P) be the sensitivity function corresponding to a parameter P k and S the matrix called the sensitivity matrix and defined by
Let W be the diagonal matrix composed of the ele ments {wJ and called the weighting matrix. The ma trix st. W.S is called the information matrix and will be denoted by M. If the data variances are unknown and if the weighting matrix is correctly justified, an approximation of the covariance matrix can be con structed as follows (Beck and Arnold, 1977; Landaw and DiStefano, 1984; Carson, 1986) :
(A4) D(P) being the residual value of the cost function and m and r being, respectively, the number of mea surements and the number of model parameters.
Let COV (P) be the parameter covariance matrix.
Assuming that the sampling distribution of the esti mate P is approximately Gaussian, an estimate of the standard error ll.Pk of parameter Pk is given by the kth diagonal element of COV(P) denoted by [COV(P)h (see, e.g., Beck and Arnold, 1977; Landawand DiStefano, 1984) . For a specified prob-J Cereb Blood Flow Metab, Vol, 11, No.6, 1991 ability level 1 -a, the asymptotic 100(1 -a)% confidence interval for parameter Pk is defined as follows:
Pk E l.e. k where (A6) and where Tl-0.12 is the indicated value of the T distribution for mr degrees of freedom (Student law). It is common to use a 95% confidence interval (a = 0.05) and a very large number of freedom degrees (> 30). In this case TI -u/ 2 is approximately equal to 1.96.
